Literature DB >> 5981053

Clinical experience with phenformin timed disintegration capsules in Indian diabetics.

M K Chhetri, N D Chowdhury, K Pal, D Bimal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5981053      PMCID: PMC2466113          DOI: 10.1136/pgmj.42.494.770

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  13 in total

1.  PHENFORMIN (DBI) IN TREATMENT OF DIABETES MELLITUS.

Authors:  M M AHUJA; G K RASTOGI; S N DHAR
Journal:  J Assoc Physicians India       Date:  1964-10

2.  Orally given combinations of drugs in diabetes mellitus therapy. Further trial.

Authors:  S B BEASER
Journal:  JAMA       Date:  1960-12-24       Impact factor: 56.272

3.  OBSERVATIONS ON CLINICAL PATTERNS OF DIABETES MELLITUS IN INDIA.

Authors:  B B TRIPATHY; B C KAR
Journal:  Diabetes       Date:  1965-07       Impact factor: 9.461

4.  A fundamental approach to hypoglycemic therapy.

Authors:  H S SADOW
Journal:  Metabolism       Date:  1963-04       Impact factor: 8.694

5.  The phenformin timed-disintegration capsule (DBI-TD) in the management of previously treated diabetic patients.

Authors:  C WELLER; A DONESA; M LINDER
Journal:  Metabolism       Date:  1962-11       Impact factor: 8.694

6.  Phenethyldiguanide--comparative study of tablets and timed-disintegration capsules.

Authors:  R S RADDING; S J ZIMMERMAN
Journal:  Metabolism       Date:  1961-03       Impact factor: 8.694

7.  Diabetes among Natal Indians.

Authors:  J E COSNETT
Journal:  Br Med J       Date:  1959-01-24

8.  Phenethyl-, amyl-, and isoamylbiguanide in the treatment of diabetes mellitus.

Authors:  W D ODELL; D C TANNER; D F STEINER; R H WILLIAMS
Journal:  AMA Arch Intern Med       Date:  1958-10

9.  Phenethylbiguanide: clinical experiences with timed-disintegration capsules in stable diabetes mellitus.

Authors:  R S RADDING; J I McHENRY; W B NEELY; F R LUMMIS
Journal:  Metabolism       Date:  1962-04       Impact factor: 8.694

10.  Blood sugar lowering effects of chlorpropamide and tolbutamide. A double blind cooperative study.

Authors:  H M Katz; G Bissel
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.